-+ 0.00%
-+ 0.00%
-+ 0.00%

Retension Pharmaceuticals Files Initial Beneficial Ownership Statement for VP, Chief Accounting Officer Robert Wong

PUBT·11/04/2026 21:45:53
Retension Pharmaceuticals Files Initial Beneficial Ownership Statement for VP, Chief Accounting Officer Robert Wong
  • Retension Pharmaceuticals' vice president and chief accounting officer, Robert Wong, filed an initial statement of beneficial ownership.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Retension Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-115961), on November 04, 2026, and is solely responsible for the information contained therein.